RWM
ABBV icon

Rockline Wealth Management’s AbbVie ABBV Stock Holding History

Rockline Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17M Sell
32,458
-446
-1% -$96K 1.56% 18
2026
Q1 		$7.16M Sell
32,904
-239
-0.7% -$53K 1.56% 16
2025
Q4 		$7.57M Buy
33,143
+403
+1% +$91.8K 1.54% 17
2025
Q3 		$7.58M Buy
32,740
+103
+0.3% +$21K 1.57% 15
2025
Q2 		$6.06M Buy
32,637
+214
+0.7% +$39.8K 1.43% 15
2025
Q1 		$6.79M Buy
32,423
+386
+1% +$75K 1.89% 14
2024
Q4 		$5.69M Buy
32,037
+1,428
+5% +$263K 1.52% 15
2024
Q3 		$6.04M Buy
30,609
+715
+2% +$133K 1.71% 13
2024
Q2 		$5.13M Buy
29,894
+1,113
+4% +$184K 1.58% 13
2024
Q1 		$5.24M Buy
28,781
+477
+2% +$82.2K 1.83% 12
2023
Q4 		$4.39M Buy
+28,304
New +$4.13M 1.82% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rockline Wealth Management's ABBV Position: Q2 2026 in Review

Rockline Wealth Management reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $96K and leaving 32,458 shares worth $8.17M. The position accounts for 1.56% of the portfolio, ranked #18.

Rockline Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rockline Wealth Management held 32,458 shares of AbbVie worth $8.17M as of Q2 2026.
  • Rockline Wealth Management sold 446 AbbVie shares in Q2 2026, an estimated $96K.
  • AbbVie made up 1.56% of Rockline Wealth Management's portfolio in Q2 2026, its #18 holding.
  • Rockline Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rockline Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.